GREENWICH LIFESCIENCES, INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f1b9f602-0e22-4bb3-9ced-a853410edeef/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-19.4M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-026651 |
| FY 2024 | $-17.6M | 2024-01-01 – 2024-12-31 | evidence 0001493152-26-026651 |
| FY 2023 | $-9.3M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014625 |
| FY 2022 | $-8.0M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-010284 |
| FY 2021 | $-4.6M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-007377 |
| FY 2020 | $-1.9M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-007532 |
| FY 2019 | $-3.4M | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-007532 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).